Gavestinel

Gavestinel (GV 150526) is a selective and potent the glycine site of the NMDA receptor antagonist. Gavestinel has neuroprotectant effects[1].

Product Specifications

CAS Number

[153436-22-7]

Product Name Alternative

GV 150526

UNSPSC

12352005

Target

IGluR

Type

Reference compound

Related Pathways

Membrane Transporter/Ion Channel; Neuronal Signaling

Applications

Neuroscience-Neurodegeneration

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/gavestinel.html

Purity

98.74

Solubility

DMSO : 125 mg/mL (ultrasonic)

Smiles

O=C(C(N1)=C(/C=C/C(NC2=CC=CC=C2)=O)C3=C1C=C(Cl)C=C3Cl)O

Molecular Formula

C18H12Cl2N2O3

Molecular Weight

375.21

References & Citations

[1]J F Hoke, et al. Pharmacokinetics of a glycine site antagonist (gavestinel) following multiple dosing in patients with acute stroke. Eur J Clin Pharmacol. 2000 Feb-Mar;55 (11-12) :867-72.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, protect from light)

Scientific Category

Reference compound1

Clinical Information

Phase 2

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

CRR3055-01 15 nmol

HMGA1 siRNA (Rat)

Ask

View Details

CRR3055-02 30 nmol

HMGA1 siRNA (Rat)

Ask

View Details

NBP3-20093JF669 0.1 mL

Rabbit Monoclonal Annexin A4 Antibody (SAIC-14C-10F12) [Janelia Fluor 669]

Ask

View Details

NB100-65411PE 0.1 mL

Rat Monoclonal HLA ABC Antibody (YTH862.2) [PE]

Ask

View Details

HY-161990 1 Each

BCL6 ligand-2

Ask

View Details

E-PP-0319-01 1 mg

[Tyr0]-BNP-32, human

Ask

View Details